IL6 and COVID-19: A recent study by Del Valle and colleagues showed that elevated levels of immune-biomarkers involved in the cytokine storm induced by COVID-19 at the time of hospitalization, like both IL-6 and TNF-α, were significantly associated with patients’ survival [19].